In the initial cohort patients with higher CRP levels had significantly more frequently cardiovascular comorbidities and infections (i.e., pneumonia and sepsis) and were treated more frequently with cardiovascular medication (Supplementary Table 2 and 3). The gene discussed is CRP; the disease is pneumonia.